Glioma-induced alterations in excitatory neurons are reversed by mTOR inhibition
Alexander Goldberg, Athanassios Dovas, Daniela Torres, Brianna Pereira, Ashwin Viswanathan, Sohani Das Sharma, Angeliki Mela, Edward M. Merricks, Cristina Megino‐Luque, Julie J. McInvale, Markel Olabarria, Leila Abrishami Shokooh, Hanzhi Zhao, Cady Chen, Corina Kotidis, Peter Calvaresi, Matei A. Banu, Aida Razavilar, Tejaswi Sudhakar, A. K. Saxena, Cole Chokran, Nelson Humala, Aayushi Mahajan, Weihao Xu, Jordan B. Metz, Eric A. Bushong, Daniela Boassa, Mark H. Ellisman, Elizabeth M. C. Hillman, Gunnar Hargus, Jose Javier Bravo‐Cordero, Guy M. McKhann, Brian Gill, Steven S. Rosenfeld, Catherine A. Schevon, Jeffrey N. Bruce, Peter A. Sims, Darcy S. Peterka, Peter Canoll
Topics & Concepts
Excitatory postsynaptic potentialGliomaDownregulation and upregulationNeurosciencePI3K/AKT/mTOR pathwayDendritic spineBiologyInhibitory postsynaptic potentialPostsynaptic potentialNeuronmTORC1NeuroplasticityCancer researchCell biologySignal transductionReceptorHippocampal formationGeneBiochemistryGlioma Diagnosis and TreatmentNeuroscience and Neuropharmacology ResearchMicrotubule and mitosis dynamics